Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Torti's Next Hundred Days: Active, Not Just Acting FDA Commissoner

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA's Chief Scientist will continue to push for outside academic collaborations during his "short time" atop the agency; fall letter on follow-on biologics could draw closer reading.

You may also be interested in...



Waxman-Hatch Generic Drug Law Architect Returns To HHS As Daschle’s Deputy

Bill Corr was one of the architects of the ANDA/patent restoration deal behind the Waxman/Hatch legislation in 1984 - and, a quarter century later, is well positioned to make sure follow-on biologics find a place in health reform.

FDA’s Torti Tapped As Acting Commissioner; Interim Heads Also Named For HHS, CMS

Chief scientist Frank Torti is a relative newcomer to FDA, having joined less than a year ago from Wake Forest University. Since then, he has headed the agency’s successful fellowship program.

Heads Of FDA, CMS And Other HHS Agencies May Be Named Within A Few Weeks

HHS Secretary-nominee Tom Daschle tells Senate HELP Committee there needs to be better coordination within the department.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel